Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London
- 31 January 2010
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (1) , 19-24
- https://doi.org/10.1016/j.ijantimicag.2009.09.014
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Polymyxin B for the treatment of multidrug-resistant pathogens: a critical reviewJournal of Antimicrobial Chemotherapy, 2007
- Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumanniiClinical Microbiology & Infection, 2007
- Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast EnglandJournal of Clinical Microbiology, 2006
- The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumanniiFEMS Microbiology Letters, 2006
- A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast EnglandJournal of Hospital Infection, 2004
- Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech RepublicJournal of Medical Microbiology, 2004
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)Journal of Antimicrobial Chemotherapy, 2002
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999